Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Eden Research plc (LON:EDEN)’s stock price traded down 3.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The business has a 50 day simple moving average of GBX 3.88 and a 200 day simple moving average of GBX 3.95. The company has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insiders Place Their Bets

In related news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). 14.02% of the stock is owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.